A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia | MicrobiomeTrials← Back to trialsNCT07799688
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-30Est. Completion: 2028-10-15
Enrollment target: 400 participants Locations- The First Affiliated Hospital of Shandong First Medical University (Qianfo Shan Hospital of shandong province)., Jinan, Shandong, China
- Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Hypercholesterolaemia
This is a study to evaluate the effect on LDL-C and the safety and tolerability of FDC laroprovstat/rosuvastatin in LLT-…
Dothan, United StatesEst. completion Jul 30, 2027
Lipid Metabolism Disorders
Background:
Obesity is known to lead to diseases such as diabetes and high cholesterol (or fats) in the blood (hyperlip…
Bethesda, United StatesEst. completion Nov 30, 2028
Recruiting
This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes …
Multiple LocationsEst. completion Dec 31, 2026